Dr Richard Smith will lead the team hoping to perform the UK's first ever womb transplant following the success of the procedure in Sweden.
Ethical approval has been granted by a special committee at Imperial College London for 10 transplants as part of a clinical trial.
It will launch in the spring and more than 100 women have been identified as potential recipients of donor wombs.
Around one in 5,000 women are born without a womb, while others lose their womb to cancer.
If the trial is successful, the first British baby born as a result of a womb transplant could arrive in late 2017 or 2018, with more in the future.
Dr Smith, 55, a consultant gynaecologist at the Queen Charlotte's and Chelsea Hospital, has been working on the project for 19 years and said he was "really pleased" to have been granted approval.
Dr Smith needs to raise £500,000 for the trial.
"I've always been an enormous optimist," he said. "The project has run with no money from the start. Somehow or other, somebody has always turned up and given us enough money to keep it going."
The 10 women who will be selected for the trial must all meet strict criteria, which includes being 38 or under, having a long-term partner and being a healthy weight.
More than 300 women have approached the Womb Transplant UK team, of which 104 meet the criteria.
Before the trial starts, embryos will be created and frozen using each woman's eggs and sperm from her partner.
The women will then undergo a six-hour transplant operation to receive a womb from a donor who is classed as brain dead but whose heart has been kept beating.
After 12 months on immunosuppressant drugs and close monitoring, each woman will be implanted with one of her embryos, with the hope of achieving a successful pregnancy.
Any baby would be delivered by Caesarean section to prevent the donor womb going through the stresses and strains of labour.
Six months after giving birth, each woman will be given the option of trying for one more baby, or the womb will be removed by surgeons.
This is to minimise the risk of keeping women on immunosuppressant drugs for the rest of their lives, which have side effects, including an increased risk of cancer.
No comments:
Post a Comment
Disclaimer: Opinions expressed in comments are those of the comment writers alone and does not reflect or represent the views of Ochuko Arhiakpore.
+2348176236720
Leave a comment